Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor

被引：48

作者：

Barluenga, Sofia ^{[1
]}

Wang, Cuihua ^{[1
]}

Fontaine, Jean-Gonzague ^{[1
]}

Aouadi, Kaiss ^{[1
]}

Beebe, Kristin ^{[2
]}

Tsutsumi, Shinji ^{[2
]}

Neckers, Len ^{[2
]}

Winssinger, Nicolas ^{[1
]}

机构：

[1] Univ Strasbourg 1, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France

[2] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2008年 / 47卷 / 23期

关键词：

antitumor agents; bioorganic chemistry; natural products; solid-phase synthesis; synthesis design;

D O I：

10.1002/anie.200800233

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Chemical Equation Presented) Make a clean breast of it: The generation of a library of pochonin Dderivatives by a solid-phase approach has led to the discovery of pochoxime (see scheme), a potent inhibitor of the heat-shock protein 90, with over 100-fold improved incellular activity. Pochoxime was found to be effective in breast tumor xenografts, leading to a reduction in the tumor size. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：4432 / 4435

页数：4

共 37 条

[21] Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells [J].

Peng, Cong ;

Brain, Julia ;

Hu, Yiguo ;

Goodrich, Ami ;

Kong, Linghong ;

Grayzel, David ;

Pak, Roger ;

Read, Margaret ;

Li, Shaoguang .

BLOOD, 2007, 110 (02) :678-685

[22] Inhibition of Hsp90 with synthesis macrolactones: Synthesis and structural and biological evaluation of ring and conformational analogs of radicicol [J].

Proisy, Nicolas ;

Sharp, Swee Y. ;

Boxall, Kathy ;

Connelly, Stephen ;

Roe, S. Mark ;

Prodromou, Chrisostomos ;

Slawin, Alexandra M. Z. ;

Pearl, Laurence H. ;

Workman, Paul ;

Moody, Christopher J. .

CHEMISTRY & BIOLOGY, 2006, 13 (11) :1203-1215

[23]

Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO

[24]

[25] Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol [J].

Sharma, SV ;

Agatsuma, T ;

Nakano, H .

ONCOGENE, 1998, 16 (20) :2639-2645

[26] Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease [J].

Sittler, A ;

Lurz, R ;

Lueder, G ;

Priller, J ;

Hayer-Hartl, MK ;

Hartl, FU ;

Lehrach, H ;

Wanker, EE .

HUMAN MOLECULAR GENETICS, 2001, 10 (12) :1307-1315

[27]

Soga S, 1999, CANCER RES, V59, P2931

[28]

Solit DB, 2003, CANCER RES, V63, P2139

[29] Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 [J].

Sydor, Jens R. ;

Normant, Emmanuel ;

Pien, Christine S. ;

Porter, James R. ;

Ge, Jie ;

Grenier, Louis ;

Pak, Roger H. ;

Ali, Janid A. ;

Dembski, Marlene S. ;

Hudak, Jebecka ;

Patterson, Jon ;

Penders, Courtney ;

Pink, Melissa ;

Read, Margaret A. ;

Sang, Jim ;

Woodward, Caroline ;

Zhang, Yilong ;

Grayzel, David S. ;

Wright, Jim ;

Barrett, John A. ;

Palombella, Vito J. ;

Adams, Julian ;

Tong, Jeffrey K. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) :17408-17413

[30] Targeting wide-range oncogenic transformation via PU24FCI, a specific inhibitor of tumor Hsp90 [J].

Vilenchik, M ;

Solit, D ;

Basso, A ;

Huezo, H ;

Lucas, B ;

He, HZ ;

Rosen, N ;

Spampinato, C ;

Modrich, P ;

Chiosis, G .

CHEMISTRY & BIOLOGY, 2004, 11 (06) :787-797

← 1 2 3 4 →